Rituximab

9 clinical trials · Condition

Record	Firm	Date
Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases (NCT05324917)	The Affiliated Hospital of Qingdao University	2022-04-10
Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab. (NCT04877496)	Insel Gruppe AG, University Hospital Bern	2021-04-26
Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis (NCT05332587)	First Affiliated Hospital, Sun Yat-Sen University	2020-08-01
Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma (NCT04425824)	Chinese Academy of Medical Sciences	2020-06-15
Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children (NCT06530004)	The First Affiliated Hospital of Xiamen University	2020-03-01
Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (NCT03373019)	Fudan University	2017-12-21
Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCL (NCT03958916)	Sun Yat-sen University	2017-05-05

Every clearance here is in the API, with alerts when new ones post.